Table 2.

Patient demographic and health information

Characteristic	First focus group Dallas, TX 2019 (n = 11)	Second focus group virtual 2020 (n = 7)	Total sample (n = 18)
Age (years)
Mean	59	62	60
Minimum–maximum	33–80	46–72	33–80
Sex (n, %)
Male	7 (63.6%)	4 (57.1%)	11 (61.1%)
Female	4 (36.4%)	3 (42.9%)	7 (38.9%)
Race/ethnicity (n, %)
White or Caucasian	9 (81.8%)	7 (100.0%)	16 (88.9%)
Data not provided	2 (18.2%)	0 (0.0%)	2 (11.1%)
Time since DLBCL diagnosis (years)
Mean	5.1	9.0	6.6
Minimum–maximum	1.3–19.8	3.5–17.5	1.3–19.8
Time since CAR T treatment (years)
Mean	1.1	1.9	1.4
Minimum–maximum	0.5–1.7	1.0–2.5	0.5–2.5

CAR T chimeric antigen receptor T-cell, DLBCL diffuse large B-cell lymphoma